The Use of Humor With Young Adults in Psychiatric Care

Sponsor
University Hospital, Geneva (Other)
Overall Status
Recruiting
CT.gov ID
NCT04778163
Collaborator
(none)
34
1
2
39.4
0.9

Study Details

Study Description

Brief Summary

Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks.

The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being.

Group 1 (test group) will participate in the humor-based sessions, while Group 2 (control group) will receive regular treatment for 6 weeks (waiting list: patients in Group 2 will attend humor-based sessions once Group 1 has completed their 6 weeks).

At the end of the 6-week sessions, both groups will receive the same series of pre-session tests to see whether or not there has been improvement in their overall functioning, psychiatric symptomatology and appreciation/use of humor.

At the end of the 2x 6-week sessions, group 2 will again receive this series of pre-session tests to see whether or not their overall functioning, psychiatric symptomatology and appreciation/use of humour has improved.

Objective(s)/Aim:

To evaluate the resilience of young adult psychiatric patients and their ability to cope with stress through the use of humor in a set of 6 modules on the use of humor.

To evaluate the symptoms.

Outcome/Endpoints :

Using scales, measure this evolution.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Clinical use of humor
N/A

Detailed Description

Project design and procedures :

The investigators will form 2 groups of 5 to 10 patients matched on their score on the sense of humor scale, their gender and their level of education. The participants will be asked to complete a series of tests measuring their ability to use humor, clinical variables and general functioning.

Group 1 - experimental - will participate in a "humor group" with a one-hour group session per week for 6 weeks.

Group 2 - the control group - will follow a usual treatment regimen for 6 weeks. At the end of the "Humor Group" of group 1, the 2 groups of patients will undergo a second series of tests identical to those of the pregroup. The paired patients should be randomly assigned. The control group will do the "Humor Group" after 6 weeks.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A treatment arm receives a psychotherapeutic group intervention (based on humor with cognitive behavioural and psychoeducative approaches) over a period 6 weeks. A control arm is placed on a 6 week waiting list.A treatment arm receives a psychotherapeutic group intervention (based on humor with cognitive behavioural and psychoeducative approaches) over a period 6 weeks. A control arm is placed on a 6 week waiting list.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Use of Humor With Young Adults in Psychiatric Care
Actual Study Start Date :
Sep 19, 2019
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Humor group 1

Group 1 - experimental - will participate in a "humor group" with a one-hour group session per week for 6 weeks.

Behavioral: Clinical use of humor
Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks. The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being.
Other Names:
  • Treatment
  • Group psychotherapy
  • No Intervention: Control group 2

    Group 2 - the control group - will follow an usual treatment regimen for 6 weeks. At the end of the "Humor Group" of group 1, the 2 groups of patients will undergo a second series of tests identical to those of the pregroup. The paired patients should be randomly assigned. The control group will do the "Humor Group" after 6 weeks.

    Outcome Measures

    Primary Outcome Measures

    1. Primary outcome is sense of humor using scale : Sense of Humor Scale (from 36 to 144 : higher scores mean a better outcome). [About three years]

      To evaluate whether or not their appreciation/use of humor has improved.

    Secondary Outcome Measures

    1. Coping evolution using scale : Coping Humor Scale (from (-14) to (+14) : higher scores mean a better outcome). [About three years]

      To evaluate whether or not the coping evolution has improved.

    2. Psychiatric symptoms evolution using scale : Brief Psychiatric Rating Scale (from 24 to 168 : higher scores mean a worse outcome). [About three years]

      To evaluate whether or not the overall psychiatric symptomatology has improved.

    3. Global functioning using scales : Global Assessment Functioning (from 1 to 100 : higher scores mean a better outcome). [About three years]

      To evaluate whether or not the overall functioning has improved.

    4. Clinical global impression using scale : Clinical Global Impression (from 1 to 7 : higher scores mean a worse outcome). [About three years]

      To evaluate whether or not the overall global clinical impression has improved.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 25 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Young adult patients of a psychiatric's unit (young people from 18 to 25 years old with beginner psychic disorders) who are French-speaking and able to give their informed consent.
    Exclusion Criteria:
    • Those who do not meet the above criteria.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Programme JADE Geneva Switzerland 1202

    Sponsors and Collaborators

    • University Hospital, Geneva

    Investigators

    • Principal Investigator: Cédric AM Devillé, Dr, University Hospital, Geneva

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Cédric DEVILLE, Medical Doctor, University Hospital, Geneva
    ClinicalTrials.gov Identifier:
    NCT04778163
    Other Study ID Numbers:
    • CDEVILLE
    First Posted:
    Mar 2, 2021
    Last Update Posted:
    May 19, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Cédric DEVILLE, Medical Doctor, University Hospital, Geneva
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 19, 2022